New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:56 EDTACRXAcelRx price target lowered to $12 from $14 at JMP Securities
JMP Securities cut its price target on AcelRx after the company received a Complete Response Letter from the FDA. The firm thinks the requests in the letter were minor, and the firm now assumes that the launch of the drug will be delayed a year until early 2016. However, it sees a 90% chance of the drug being approved and keeps an Outperform rating.
News For ACRX From The Last 14 Days
Check below for free stories on ACRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
11:06 EDTACRXOptions with increasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use